Esperion Therapeutics News (NASDAQ:ESPR)

Add to My Stocks
$49.31 $0.06 (0.12%) ESPR stock closing price Sep 22, 2017 (Closing)
Esperion Prices Public Offering of Common Stock   by Globe Newswire on Aug 09, 2017

ESPR Industry Peers

Company Price Change (%)
Usana Health Sciences (USNA)56.550.8 (1.43%)
Therapeuticsmd (TXMD)6.170.06 (0.96%)
Aegerion Pharma (AEGR)1.970.1 (5.35%)
Gemphire Therap (GEMP)9.880.36 (3.52%)
Regeneron Pharma (REGN)432.720.73 (0.17%)
Abbvie (ABBV)87.480.07 (0.08%)
Merck (MRK)65.130.47 (0.72%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)34.1811.85 (53.07%)
SEVEN STARS CLD (SSC)2.210.47 (27.01%)
Aralez Pharma (ARLZ)1.80.28 (18.42%)
Quad Graphics (QUAD)22.582.81 (14.21%)
Aegean Marine Petroleum (ANW)4.650.55 (13.41%)
Oramed Pharma (ORMP)10.711.21 (12.74%)
Mesabi (MSB)23.452.55 (12.2%)
Top gainers from NASDAQ & NYSE ( Above $100M Market Cap )
* As of Sep 23, 2017
CompanyPriceChange (%)
Versartis (VSAR)2.67518.93 (87.64%)
Revolution Lighting (RVLT)6.261.32 (17.41%)
Intercept Pharma (ICPT)61.5912.11 (16.43%)
Compass Minerals (CMP)60.19.4 (13.53%)
Exelixis (EXEL)24.473.54 (12.64%)
Epizyme (EPZM)16.951.75 (9.36%)
Matson (MATX)26.352.32 (8.09%)
Top losers from NASDAQ & NYSE ( Above $100M Market Cap )
* As of Sep 23, 2017